Letters
Aspirin “resistance”
What is the risk of cardiovascular morbidity?
BMJ 2008; 336 doi: https://doi.org/10.1136/bmj.39479.465706.3A (Published 07 February 2008) Cite this as: BMJ 2008;336:291- Peter Elwood, honorary professor,
- Gareth Morgan, secretary, Welsh Aspirin Group
- 1Department of Primary Care and Public Health, Cardiff University Cardiff CF10 3XQ
- pelwood{at}doctors.org.uk
The increased risk of vascular disease in a subgroup of patients judged to be “resistant” to aspirin led Krasopoulos et al to propose that there could be beneficial effect of aspirin of greater than 50% in aspirin sensitive patients.1
The problem is identifying subjects “resistant” to aspirin. Krasopoulos et al accepted evidence from the authors of 20 …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.